human protein -derived antiangiogenic (NUS/ProTherapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namehuman protein -derived antiangiogenic (NUS/ProTherapeutics)
Drug Alias NameN/A
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsMacular DegenerationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational University Of Singapore
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProTherapeutics Pte LtdNational University Of Singapore
Active IndicationsN/A
Inactive IndicationsMacular DegenerationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A